CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology.

Cancers (Basel) · 2021 · PMC8124456 · PMID 34063285

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In this study, the incidence of cholangiocarcinoma is significantly increased by 77% in DPP-4 inhibitor users (HR 1.77, 95%CI: 1.04–3.01), and an increasing trend in GLP-1 receptor agonist (GLP-1RA) users as well (HR 1.97, 95%CI: 0.83–4.66).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.